BIN1 and prostate carcinoma: Thus, Lodygin et al. report reactivation of BIN1 in one of the three prostate cancer cell lines, DU145, after 5-aza-2'-deoxycytidine treatment which suggested epigenetic regulation of the gene expression by promoter methylation.